Introduction Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) is a promising respiratory support method for avoiding invasive mechanical ventilation in neonatal intensive care units (NICUs). However, its effectiveness and safety have not been widely established through clinical evidence. In this study, we aim to evaluate the feasibility of NIV-NAVA as a primary respiratory support method after birth and its effects on short-term clinical outcomes and long-term neurodevelopment in preterm infants. Methods and analysis In this prospective multicentre observational study, 230 preterm…
Objectives This study aimed to analyse temporal trends in fertility and birth rates, examine maternal characteristics and forecast future demographic changes in Georgia. Design This was a retrospective observational study using population-level data from the National Statistics Office of Georgia (Geostat) and the Georgian Birth Registry (GBR). Temporal trends were analysed using Prais-Winsten regression models and annual percentage changes (APCs) and future projections were generated using autoregressive integrated moving average (ARIMA) models. Participants The study included data on 543 662…
Introduction Poststroke depression (PSD) affects approximately 33% of stroke survivors and is associated with worse outcomes, poor quality of life (QOL) and mortality. Despite its prevalence and consequences, there is no consensus on the most effective strategy for PSD prevention. Behavioural activation (BA) is an effective intervention for depression across diverse populations and is considered safer, better tolerated and a longer-lasting alternative to antidepressant medications. This study aims to test the effectiveness of a remotely delivered BA intervention to prevent PSD (Tele-BA-S)…
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health mcarmody Sun, 06/07/2026 - 06:28 Press release Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health NEW ORLEANS, La. June 7, 2026 Injectable Offers Potential to Reduce Fatty Liver Diseases and Improve Health Markers in Adults New data highlight the potential benefits of survodutide, a once-weekly injectable therapy targeting both the glucagon and glucagon-like peptide-1 (GLP-1) receptors in individuals with obesity and metabolic dysfunction-associated…
The American Diabetes Association Announces Winners of the Innovation Challenge mcarmody Sat, 06/06/2026 - 18:52 Press release The American Diabetes Association Announces Winners of the Innovation Challenge NEW ORLEANS, La. June 6, 2026 Today, from the main stage at the organization’s 2026 Scientific Sessions, the American Diabetes Association ® (ADA) announced the winners of the 2026 Innovation Challenge competition. Each year, the Innovation Challenge seeks game-changing ideas from emerging companies that have the potential to transform diabetes care. “There is tremendous…
Winona launched a new research initiative to fund and support menopause and women’s health research. The post Winona Launches Menopause Research Initiative appeared first on MedCity News .
Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily topical gel and an implantable option. The post Contraline Secures $92.5M to Push Its Male Birth Control Candidates Forward appeared first on MedCity News .
Nelson & Isa Lacteos LLC. of Bayshore, NY, is recalling 1lb packages of Requeson Cheese because they may be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems